IJSTR

International Journal of Scientific & Technology Research

Home About Us Scope Editorial Board Blog/Latest News Contact Us
0.2
2019CiteScore
 
10th percentile
Powered by  Scopus
Scopus coverage:
Nov 2018 to May 2020

CALL FOR PAPERS
AUTHORS
DOWNLOADS
CONTACT

IJSTR >> Volume 8 - Issue 5, May 2019 Edition



International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616



A Rare Of Malignancy In The Young Patient: Cholangiocarsinoma

[Full Text]

 

AUTHOR(S)

Uğur Ergün, Gülhan Zorgör Uçdu, Merve Nur Ak, Erkan Çağlar, Emrah Akay, Eren Altun

 

KEYWORDS

Biliary, cholangiocarcinoma, malignant, icterus, pain, patient, young,

 

ABSTRACT

Cholangiocarcinoma (CCA) is one of the primary malignant tumors of the liver caused by biliary epithelium. Approximately 15-25 percent of hepatobiliary malignancies. The incidence is increasing with age and it is generally seen between the ages of 50-70. Many reasons such as infection, biliary stasis and carcinogens are risk factors and the exact cause is unknown. The clinical picture of CCA varies according to the localization of the solitary lesion. Surgical treatment is the only curative method for patients with CCA. It is not very common for cholangiocarcinoma, a malignancy of hepatobiliary origin, to appear at an early age. In this article, we present a case of CCA in a young patient presenting with nausea, weight loss and abdominal pain.

 

REFERENCES

[1] Khan SA, Davidson BR, Goldin RD, et al; British Society of Gastroenterology. Guidelines for the diagnosisand treatment ofcholangiocarcinoma:un update. Gut 2012; 61:1657-69.

[2] Stinton LM, Shaffer EA: Epidemiolgy of gallbladder disease: cholelithiasis and cancer, Gut Liver 6: 172-187,2012.

[3] Shaffer EA: Epidemiogly of gallbladder disease, Best Pract Res Clin Gastroenterol 20:981-996,2006.

[4] Tazuma S: Epidemiology, pathogenesis, and classification of biliary Stones (common bile duct and intraheptic), Best Pract Clin Gastroenterol 20:1075-1083,2006.

[5] Patel T. New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma. J Gastroenterol 2014; 49:165-72. Epub 2013 Oct 22.

[6] Fan B, Malato Y, Calvisi DF, et al. Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest 2012; 122:2911-5.

[7] Sirica AE. Notching up on the cellular origins of intrahepatic cholangiocarcinoma. Hepatology 2013; 57:1668-71.

[8] Zabron A, Edwards RJ, Khan SA. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer. Dis Model Mech 2013; 6:281-92.